Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating Activities
Net income	$ 52,681	$ 44,675	$ 29,540
Adjustments to reconcile net income to net cash provided (used) by operating activities
Deferred income taxes	2,786	(4,434)	337
Provision for loan losses	(3,500)	10,900	7,312
Depreciation and amortization	8,868	8,950	8,768
Amortization and accretion of premiums/discounts on investment securities	3,744	1,760	1,127
Amortization of operating lease right-of-use assets	(58)	(25)
Stock-based compensation	3,095	1,927	1,750
Increase in value of bank-owned life insurance	(793)	(797)	(803)
Realized loss (gain) on sale of branch			(1,544)
Realized loss (gain) on sale of fixed assets	(62)	707	(541)
Realized loss (gain) on derivative instruments	8,459	1,927	(2,051)
Realized loss (gain) on loans sold	(48,038)	(57,070)	(18,942)
Realized loss (gain) on sale of foreclosed assets	(275)	(28)	(122)
Realized loss (gain) on sale of investment securities	(125)	(2,737)	(357)
Realized loss (gain) on servicing rights	(638)	936	(209)
Net change in:
Securities held for trading			1,539
Loans held for sale	123,945	(18,621)	(13,146)
Accrued interest receivable	1,125	(2,111)	12
Other assets	(7,963)	(2,694)	4,399
Accrued expenses and other liabilities	5,865	(5,527)	2,179
Net cash provided (used) by operating activities	149,116	(22,262)	19,248
Investing Activities
Proceeds from sales or calls of investment securities available-for-sale	13,189	75,647	32,565
Proceeds from maturities of investment securities available-for-sale	125,581	69,680	37,109
Purchases of investment securities available-for-sale	(571,595)	(414,724)	(123,226)
Proceeds from sales or calls of investment securities held-to-maturity	1,772
Proceeds from maturities of investment securities held-to-maturity	12,545
Purchases of investment securities held-to-maturity	(218,363)
Net (increase) decrease in equity securities		2,808	357
Net (increase) decrease in loans	221,006	(259,130)	(21,898)
Net cash paid for business combinations		(9,279)
Proceeds from sale of branch			10,379
Proceeds from sale of fixed assets			875
Purchases of premises and equipment	(1,706)	(3,811)	(2,901)
Proceeds from sales of foreclosed assets	629	429	1,146
Net cash provided (used) by investing activities	(416,942)	(538,380)	(65,594)
Financing Activities
Net increase (decrease) in deposits	348,558	600,677	191,444
Net increase (decrease) in short-term borrowings			(93,460)
Repayments of long-term debt	(49,920)	(210)	(230)
Proceeds from the issuance of subordinated debt	50,000
Cash dividends paid on common stock	(10,751)	(10,387)	(8,909)
Repurchase of common stock	(712)	(482)	(1,948)
Proceeds from the issuance of common stock in initial public offering net of issuance costs			62,804
Net cash provided (used) by financing activities	337,175	589,598	149,701
Net change in cash and cash equivalents	69,349	28,956	103,355
Cash and cash equivalents at beginning of period	172,962	144,006	40,651
Cash and cash equivalents at end of period	242,311	172,962	144,006
Cash paid for:
Interest	4,538	12,641	18,431
Income taxes	13,124	13,582	7,219
Cash and cash equivalents acquired		513
Non-cash information
Loan collateral transferred to foreclosed assets	1,176	456	828
Unrealized gain (loss) on investment securities available-for-sale	(14,567)	8,702	5,537
Accretion of unrealized (gain) loss on investment securities held-to-maturity	(326)
Investment securities transferred to held-to-maturity	149,191
Initial recognition of operating lease right-of-use assets			10,485
Initial recognition of operating lease liabilities			11,006
Right-of-use assets obtained in exchange for new operating leases	$ 267	1,555
ESOP repurchase obligation termination			$ 34,494
Noncash assets acquired		14,627
Liabilities assumed		(5,348)
Net noncash acquired		$ 9,279